nelfinavir has been researched along with Cytomegalic Inclusion Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boucoiran, I; Burchett, S; Frenkel, L; Gantt, S; Huang, ML; Jacobsen, DL; Jerome, KR; Jourdain, G; Leister, E; Ngo-Giang-Huong, N | 1 |
Bubl, R; Di Gallo, A; Engelcke, G; Rinaldi, D; Rohrer, T; Rudin, C | 1 |
Durand, H; Gisselbrecht, M; Haas, C; Lowenstein, W; Marteau, P; Roudière, L | 1 |
Mönkemüller, KE; Wilcox, CM | 1 |
1 review(s) available for nelfinavir and Cytomegalic Inclusion Disease
Article | Year |
---|---|
Combined treatment with zidovudine, lamivudine, nelfinavir and ganciclovir in an infant with human immunodeficiency virus type 1 infection and cytomegalovirus encephalitis: case report and review of the literature.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cytomegalovirus Infections; Diseases in Twins; Drug Therapy, Combination; Encephalitis, Viral; Female; Ganciclovir; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lamivudine; Nelfinavir; Zidovudine | 1999 |
3 other study(ies) available for nelfinavir and Cytomegalic Inclusion Disease
Article | Year |
---|---|
Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
Topics: Adult; CD4-Positive T-Lymphocytes; Cohort Studies; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Risk Factors; Young Adult | 2016 |
[Severe cytomegalovirus enteritis in AIDS. Favorable outcome of medical treatment].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Celiac Disease; Cytomegalovirus Infections; Foscarnet; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Parenteral Nutrition; Pentamidine; Protein-Losing Enteropathies; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Treatment Outcome | 2000 |
Esophageal ulcer caused by cytomegalovirus: resolution during combination antiretroviral therapy for acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Biopsy; CD4 Lymphocyte Count; Cytomegalovirus Infections; Drug Therapy, Combination; Endoscopy, Digestive System; Esophagitis; Humans; In Situ Hybridization; Lamivudine; Male; Nelfinavir; Ulcer; Wound Healing; Zidovudine | 2000 |